These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21127767)

  • 1. What is the optimum duration of anticoagulation for the management of patients with idiopathic deep venous thrombosis and pulmonary embolism?
    Hyers TM; Shetty HG; Campbell IA
    J R Coll Physicians Edinb; 2010 Sep; 40(3):224-8. PubMed ID: 21127767
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the optimal duration of treatment for DVT? An update on evidence-based medicine of treatment for DVT.
    East AT; Wakefield TW
    Semin Vasc Surg; 2010 Sep; 23(3):182-91. PubMed ID: 20826296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux for the treatment of superficial-vein thrombosis in the legs.
    Decousus H; Prandoni P; Mismetti P; Bauersachs RM; Boda Z; Brenner B; Laporte S; Matyas L; Middeldorp S; Sokurenko G; Leizorovicz A;
    N Engl J Med; 2010 Sep; 363(13):1222-32. PubMed ID: 20860504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolism.
    Fitzmaurice DA; Hobbs FD; McManus RJ
    Am Fam Physician; 2002 Aug; 66(3):475-7. PubMed ID: 12182526
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries].
    Lewandowski K; Szturmowicz M; Fijałkowska A; Kurzyna M; Hajduk B; Burakowska B; Chmielewski D; Torbicki A
    Pneumonol Alergol Pol; 2002; 70(3-4):203-9. PubMed ID: 12271967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 9. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes.
    Kearon C
    J Thromb Haemost; 2007 Dec; 5(12):2330-5. PubMed ID: 18034763
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 11. The case for managing calf vein thrombi with duplex surveillance and selective anticoagulation.
    Masuda EM; Kistner RL
    Dis Mon; 2010 Oct; 56(10):601-13. PubMed ID: 20971331
    [No Abstract]   [Full Text] [Related]  

  • 12. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.
    Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D
    Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer].
    Schulman S
    Lakartidningen; 2004 May; 101(19):1712-5. PubMed ID: 15188585
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.
    Baglin T; Bauer K; Douketis J; Buller H; Srivastava A; Johnson G;
    J Thromb Haemost; 2012 Apr; 10(4):698-702. PubMed ID: 22332937
    [No Abstract]   [Full Text] [Related]  

  • 17. [Deep vein thrombosis: how to care for risk patients].
    Kröger K; Moerchel C
    MMW Fortschr Med; 2010 Nov; 152(44):35-9; quiz 40. PubMed ID: 21158174
    [No Abstract]   [Full Text] [Related]  

  • 18. [Venous thromboembolism and cancer].
    Ferrari E; Benhamou M; Berkane N; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1307-12. PubMed ID: 11794974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
    Zufferey PJ; Samama CM; Rosencher N
    Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood clot in the lungs. Prompt treatment may be lifesaving.
    Mayo Clin Health Lett; 2012 Sep; 30(9):1-3. PubMed ID: 23097809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.